should glp-1 agonists be open access Frontiers Frontiers | GLP−1 receptor agonists

GLP-1 Receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody

The gastrointestinal side effects (oily stools, flatulence, fecal urgency) are well-documented and directly tied to dietary fat intake

doi:10.1523/JNEUROSCI.2107-12.2012 48

At the end of the study period, the reductions in the albumin-to-creatine ratios (UACR) of the liraglutide (3.0 mg), liraglutide (1.8 mg), and placebo groups were 18.36, 10.79, 2.34%, respectively ( 2 ] were randomly assigned to receive liraglutide (1.8 mg) or placebo for 26 weeks

The standard dose charts you find online do not cover this concentration

Conclusions GLP-1 agonists have become a cornerstone of cardiovascular medicine by showing substantial reductions in MACE and heart failure events and stroke, along with potential benefits for vascular dementia